Skip to main content

Wound of Skin

1
Pipeline Programs
6
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

MedRegen
MedRegenMD - Baltimore
1 program
1
MRG-001Phase 21 trial
Active Trials
NCT05844527Completed10Est. Sep 2024
Baxter
BaxterCosta Rica - Cartago
1 program
DermaClose Continuous External Tissue Expander DeviceN/A
Baxter International
1 program
DermaClose Continuous External Tissue Expander DeviceN/A1 trial
Active Trials
NCT05330767Terminated7Est. Nov 2023
Sanara MedTech
Sanara MedTechTX - Fort Worth
1 program
Normal Saline and Amorphous gelN/A1 trial
Active Trials
NCT05107050Unknown60Est. May 2023
Nanomedic Technologies
1 program
SPINNERN/A1 trial
Active Trials
NCT02680106Completed41Est. Dec 2017
SoftOx
SoftOxNorway - Fornebu
1 program
SWISN/A1 trial
Active Trials
NCT04771819Completed20Est. Jul 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MedRegenMRG-001
Baxter InternationalDermaClose Continuous External Tissue Expander Device
Sanara MedTechNormal Saline and Amorphous gel
SoftOxSWIS
Nanomedic TechnologiesSPINNER

Clinical Trials (5)

Total enrollment: 138 patients across 5 trials

NCT05844527MedRegenMRG-001

Safety and Efficacy of MRG-001 in Wound Healing in Abdominoplasty Patients

Start: Nov 2023Est. completion: Sep 202410 patients
Phase 2Completed
NCT05330767Baxter InternationalDermaClose Continuous External Tissue Expander Device

DermaClose DUKE Fasciotomy and Wound Study

Start: Aug 2022Est. completion: Nov 20237 patients
N/ATerminated
NCT05107050Sanara MedTechNormal Saline and Amorphous gel

Comparing a Synergistic Antimicrobial Cleanser and Gel to Normal Saline and an Amorphous Gel in Reducing Bioburden and Promoting Healing in Chronic Lower Extremity Ulcers

Start: Dec 2021Est. completion: May 202360 patients
N/AUnknown
NCT04771819SoftOxSWIS

Safety and Performance of SWIS in Superficial Wounds

Start: Nov 2020Est. completion: Jul 202120 patients
N/ACompleted
NCT02680106Nanomedic TechnologiesSPINNER

Evaluation of the SPINNER Device for the Application of Wound Dressing: Treatment of Split Skin Graft Donor Sites

Start: Feb 2016Est. completion: Dec 201741 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.